Telomir PharmaceuticalsTELO
13F holders, Q1 2026 (March 31)27holders −6
2new positions
10sold out
1famous investor
$1.30avg. 13F price*
At the end of Q1 2026, 27 institutions reported holding Telomir Pharmaceuticals Inc. (TELO) in their 13F filings, down 6 from Q4 2025. 2 opened new positions and 10 sold out. The largest holders were Vanguard Capital Management LLC ($1.3M), BlackRock, Inc. ($376K) and Geode Capital Management, LLC ($324K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Telomir Pharmaceuticals Inc.
- CUSIP
- 87975F104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $14K |
| Exits | 10 | $70K |
All 13F filers, Q4 2025 → Q1 2026: 53,294 shares bought and 98,743 shares sold, net −45,449 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Vanguard Capital Management LLC | 0.00% | — | 995,373 | $1.3M |
| BlackRock, Inc. | 0.00% | Add +1.3% | 289,198 | $376K |
| Geode Capital Management, LLC | 0.00% | Add +11.4% | 249,086 | $324K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 135,541 | $176K |
| Millennium Management | 0.00% | Reduce -22.7% | 129,060 | $168K |
| State Street Corp. | 0.00% | No change | 58,600 | $76K |
| Bank of New York Mellon Corp | 0.00% | No change | 51,454 | $67K |
| Suncoast Equity Management | 0.01% | No change | 51,194 | $67K |
| Northern Trust Corp. | 0.00% | No change | 41,844 | $54K |
| World Investment Advisors | 0.00% | Add +4.5% | 37,037 | $48K |
| XTX Topco Ltd | 0.00% | Reduce -9.2% | 36,061 | $47K |
| Osaic Holdings, Inc. | 0.00% | Add +5.9% | 35,795 | $47K |
| OneDigital Investment Advisors LLC | 0.00% | No change | 23,000 | $30K |
| Praetorian Wealth Management, Inc. | 0.01% | Add +100.0% | 20,000 | $27K |
| Vestmark Advisory Solutions, Inc. | 0.00% | No change | 13,100 | $17K |
| Morton Capital Management LLC | 0.00% | No change | 12,658 | $16K |
| Clearstead Advisors, LLC | 0.00% | No change | 12,530 | $16K |
| Kestra Private Wealth Services, LLC | 0.00% | No change | 11,000 | $14K |
| Regions Financial Corp. | 0.00% | No change | 10,638 | $14K |
| Goldman Sachs Group Inc. | 0.00% | New | 10,411 | $14K |
| UBS Group AG | 0.00% | Reduce -34.4% | 9,213 | $12K |
| Vanguard Global Advisers, LLC | 0.00% | — | 6,552 | $9K |
| Jones Financial Companies LLLP | 0.00% | No change | 600 | $750 |
| BNP Paribas Financial Markets | 0.00% | No change | 206 | $268 |
| JPMorgan Chase & Co. | 0.00% | No change | 121 | $138 |
| SBI Securities Co., Ltd. | 0.00% | No change | 4 | $5 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 2 | $3 |
"% of holder's portfolio" is TELO's weight in each manager's 13F, not the share of Telomir Pharmaceuticals Inc. the manager owns.